Wigal SB (2009). "Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults". CNS Drugs. 23 Suppl 1: 21–31. doi:10.2165/00023210-200923000-00004. PMID19621975.
Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M (2011). Castells X (ed.). "Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults". Cochrane Database Syst. Rev. (6): CD007813. doi:10.1002/14651858.CD007813.pub2. PMID21678370.
Storebø, OJ; Ramstad, E; Krogh, HB; Nilausen, TD; Skoog, M; Holmskov, M; Rosendal, S; Groth, C; Magnusson, FL; Moreira-Maia, CR; Gillies, D; Buch Rasmussen, K; Gauci, D; Zwi, M; Kirubakaran, R; Forsbøl, B; Simonsen, E; Gluud, C (25 November 2015). "Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)". The Cochrane database of systematic reviews. 11: CD009885. doi:10.1002/14651858.CD009885.pub2. PMID26599576.
Wigal SB (2009). "Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults". CNS Drugs. 23 Suppl 1: 21–31. doi:10.2165/00023210-200923000-00004. PMID19621975.
Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M (2011). Castells X (ed.). "Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults". Cochrane Database Syst. Rev. (6): CD007813. doi:10.1002/14651858.CD007813.pub2. PMID21678370.
Storebø, OJ; Ramstad, E; Krogh, HB; Nilausen, TD; Skoog, M; Holmskov, M; Rosendal, S; Groth, C; Magnusson, FL; Moreira-Maia, CR; Gillies, D; Buch Rasmussen, K; Gauci, D; Zwi, M; Kirubakaran, R; Forsbøl, B; Simonsen, E; Gluud, C (25 November 2015). "Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)". The Cochrane database of systematic reviews. 11: CD009885. doi:10.1002/14651858.CD009885.pub2. PMID26599576.